Security key
53630X203
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)
CUSIP: 53630X203
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 8,072,317
- Total 13F shares
- 483,800
- Share change
- -15,305
- Total reported value
- $1,345,652
- Price per share
- $2.78
- Number of holders
- 18
- Value change
- -$46,888
- Number of buys
- 5
- Number of sells
- 6
Report period
Q4 2023
Institutions
18
Top holders
10
LPCN full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
Lipocine Inc. SEC filings
Lipocine Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53630X203
Recent filing periods:
Top shareholders of LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
221,459
|
$659,948 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.93%
|
74,846
|
$223,041 | — | 30 Sep 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.71%
|
56,922
|
$169,628 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
48,854
|
$143,656 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.31%
|
25,329
|
$74,467 | — | 30 Sep 2023 | |
| WEALTH EFFECTS LLC |
13F
|
Company |
0.23%
|
18,761
|
$55,908 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.23%
|
18,626
|
$54,760 | — | 30 Sep 2023 | |
| Kestra Advisory Services, LLC |
13F
|
Company |
0.21%
|
16,703
|
$49,775 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.19%
|
15,597
|
$46,000 | — | 30 Sep 2023 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.01%
|
765
|
$2,000 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
722
|
$2,152 | — | 30 Sep 2023 | |
| CALDWELL SUTTER CAPITAL, INC. |
13F
|
Company |
0.01%
|
471
|
$1,404 | — | 30 Sep 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
254
|
$757 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
183
|
$538 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
68
|
$201 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
59
|
$176 | — | 30 Sep 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
59
|
$173 | — | 30 Sep 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
52
|
$153 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
42
|
$125 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
39
|
$116 | — | 30 Sep 2023 | |
| Morgan R. Brown |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
176,000
|
$46,746 | — | 07 Dec 2021 | |
| George Nomikos |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
125,000
|
$33,200 | — | 01 Nov 2022 |
Institutional Holders of Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) as of Q4 2023
As of 31 Dec 2023,
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
483,800 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, WEALTH EFFECTS LLC, Tower Research Capital LLC (TRC), and MORGAN STANLEY.
This page lists
18
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
20
Q4 2023 holders
18
Holder diff
-2
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.